Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aberdeen Global Equity Fund Institutional Service Class (GLLSX)

12.92
Net Asset Value
+0.08%
1 Day
-2.86%
Year-to-Date
Overall Morningstar Rating
World stock
Style or Category
No Load
Sales Expenses
1.19%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long term capital growth. The fund normally invests at least 80% of the value of its net assets, plus any borrowings for investment purposes, in equity securities issued by companies located throughout the world (including the U.S.). Equity securities include, but are not limited to, common stock, preferred stock and depositary receipts. Under normal conditions, it invests in securities from at least three different countries. The fund may also invest in companies of emerging market countries. In addition, it may invest in securities of any market capitalization.

Performance

1 month-1.00% 3 years+5.64%
3 months-5.69% 5 years+7.16%
1 year-9.18% Since inception+8.44%
Data through --

Peer Comparisonvs. World stock

 GLLSXCategory
Performance 5-yr return+7.16%+12.29%
Expense ratio1.19%1.37%
Risk 5 year sharpe ratio0.690.91
Net assets$96.9M$1.3B
Average market cap$70.6B$42.2B
Average P/E16.118.2
Portfolio turnover24%24%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAberdeen
Fund manager & tenureStephen Docherty / 6 Years
Minimal initial investment$1,000,000.00
Minimum IRA investment--

Holdings

International stock64.64%
U.S. stock31.54%
Cash3.79%
Fixed income0.03%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
CVS CVS Caremark3.71%
EOG EOG Resources Inc3.46%
-- 3.43%
-- 3.42%
-- 3.09%
TSM Taiwan Semiconductor3.02%
ORCL Oracle2.82%
-- 2.57%
PEP Pepsi2.53%
JNJ Johnson & Johnson2.50%